Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

DTIL stock hub

Precision BioSciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

DTILis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

198.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

DTIL

In the news

Latest news · DTIL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-70.9

P25 -106.6P50 -46.9P75 -3.1

ROIC-26.6

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All DTIL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

214

Groups with data

Currency

USD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001357874
Company name	Precision BioSciences, Inc.
Country	United States
Country code	US
Cusip	74019P108
Employees	68
Employees Change	-40%
Employees Change Percent	-37.04
Enterprise value	$125.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-03-28
Isin	US74019P2074
Last refreshed	2026-05-10
Market cap	$198.4M
Market cap category	Micro-Cap
Price	$7.69
Price currency	USD
Rev Per Employee	662,838.24x
Sector	Healthcare
Sic	2836
Symbol	DTIL
Website	https://precisionbiosciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-21.97%
EV Sales Forward	10.69x
EV/Sales	2.79x
FCF yield	-29.62%
P/B ratio	2.61x
P/S ratio	4.4x
PS Forward	16.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-86.77%
EBITDA Margin	-83.73%
Gross margin	100%
Gross Profit	$45.1M
Gross Profit Growth	-11.87%
Gross Profit Growth Q	37,272.41%
Gross Profit Growth3 Y	13.83%
Gross Profit Growth5 Y	6.03%
Net Income	$-43.6M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-98.7%
Profit Margin	-96.73%
Profit Per Employee	$-641,176
ROA	-18.22
Roa5y	-15.63
ROCE	-28.73
ROE	-70.93
Roe5y	-58.45
ROIC	-26.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	48.5%
Cagr3y	-32.93%
Cagr5y	-50.46%
EPS Growth Quarters	3
EPS Growth Years	0
Revenue Growth	-11.87x
Revenue Growth Q	37,272.41x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	13.83x
Revenue Growth5 Y	6.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.34
Assets	$143.9M
Cash	$101.2M
Current Assets	$108.7M
Current Liabilities	$7.8M
Debt	$28.5M
Debt Equity	$0.37
Equity	$76.1M
Interest Coverage	-28.36
Liabilities	$67.8M
Long Term Assets	$35.2M
Long Term Liabilities	$60M
Net Cash	$72.7M
Net Cash By Market Cap	$36.65
Net Cash Growth	53.17%
Net Debt Equity	$-0.96
Tangible Book Value	$75M
Tangible Book Value Per Share	$2.91
WACC	10.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.02
Net Working Capital	$1.3M
Quick ratio	13.56
Working Capital	$100.9M
Working Capital Turnover	$0.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-111.15%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	48.46%
200-day SMA	5.35
3Y total return	-69.84%
50-day SMA	6.41
50-day SMA vs 200-day SMA	50over200
5Y total return	-97.01%
All Time High	710.1
All Time High Change	-98.92%
All Time High Date	2019-12-09
All Time Low	3.53
All Time Low Change	117.85%
All Time Low Date	2026-02-05
ATR	0.53
Beta	1.31
Beta1y	0.89
Beta2y	0.49
Ch YTD	84.86
High	7.96
High52	8.82
High52 Date	2025-10-29
High52ch	-12.81%
Low	7.49
Low52	3.53
Low52 Date	2026-02-05
Low52ch	117.85%
Ma50ch	19.93%
Premarket Change Percent	1.07
Premarket Price	$7.56
Premarket Volume	240
Price vs 200-day SMA	43.85%
RSI	61.45
RSI Monthly	39.91
RSI Weekly	65.29
Sharpe ratio	0.86x
Sortino ratio	1.42
Total Return	-111.15%
Tr YTD	84.86
Tr1m	22.84%
Tr1w	5.63%
Tr3m	102.37%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Price Target Top	$60
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.7
Earnings Revenue Estimate	4,780,000x
Earnings Revenue Estimate Growth	16,382.76x
Operating Income	$-39.1M
Operating margin	-86.77
Price target	$45
Price Target Change	$485
Price Target Change Top	$680

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20,429,920%
Float Percent	79.18%
Shares Insiders	4.16%
Shares Institutions	47.49%
Shares Out	25,803,199
Shares Qo Q	28.49%
Shares Yo Y	111.15%
Short Float	6.11%
Short Ratio	3.41
Short Shares	4.84

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-67.7M
Average Volume	203,876.75x
Bv Per Share	2.95
CAPEX	$-39,000
Ch1m	22.84
Ch1w	5.63
Ch1y	48.46
Ch3m	102.4
Ch3y	-69.84
Ch5y	-97.01
Ch6m	25.24
Change	2.81%
Change From Open	2.53
Close	7.48
Days Gap	0.27
Depreciation Amortization	1,372,000
Dollar Volume	1,404,816.9
Earnings Date	2026-05-05
Earnings Time	bmo
EBIT	$-39.1M
EBITDA	$-37.7M
EPS	$-2.62
F Score	2
FCF	$-58.8M
FCF EV Yield	-46.75x
FCF Per Share	$-2.28
Financing CF	85,220,000
Fiscal Year End	December
Founded	2,006
Investing CF	-434,000
Ipr	-51.94
Iprfo	-98.58
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2024-02-14
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	5.5
Ma150ch	39.84%
Ma20	7.4
Ma20ch	3.96%
Net CF	26,058,000
Next Earnings Date	2026-08-06
Open	7.5
Optionable	Yes
Position In Range	42.55
Post Close	7.69
Postmarket Change Percent	-1.82
Postmarket Price	$7.55
Ppne	6,647,000
Pre Close	7.48
Price Date	2026-05-08
Ptbv Ratio	2.65
Relative Volume	0.9x
Revenue	45,073,000x
SBC By Revenue	19.77x
Share Based Comp	8,913,000
Tr6m	25.24%
Us State	North Carolina
Volume	182,681

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does DTIL pay a dividend?

Capital-return profile for this ticker.

Performance

DTIL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns DTIL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+47.5%

Float: +79.2% of shares outstanding

Insider ownership

+4.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

DTIL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.5

Neutral momentum band

Price vs 200-day MA

+43.8%

50/200-day relationship not available

Beta (5Y)

1.31

More volatile than the market

Sharpe ratio

0.86

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About DTIL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current DTIL stock rating?

Precision BioSciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full DTIL analysis?

The full report lives at /stocks/DTIL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for DTIL?

The latest report frames DTIL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the DTIL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.